Skip to main content
. 2012 Feb 12;1(1):31–43. doi: 10.5501/wjv.v1.i1.31

Table 6.

Additional tests in the case of a simultaneous Epstein-Barr virus nuclear antigen 1 IgG, viral capsid antigen IgG and IgM positive pattern

Tests Advantages Disadvantages
EBV IgM immunoblotting Useful only in verifying the specificity of EBV IgM Not useful in distinguishing late primary infection (transient) from reactivation; expensive
HCMV IgM Parvovirus IgM Useful in verifying the specificity of EBV IgM Not useful in distinguishing late primary infection (transient) from reactivation
EBV IgG immunoblotting Only useful in verifying the specificity of EBNA-1 IgG Not useful in distinguishing late primary infection (transient) from reactivation; expensive
IgG avidity Useful in distinguishing primary infection (transient) from reactivation Individual maturation
Molecular biology Useful for EBV reactivation follow-up Difficult to distinguish late primary infection (transient) from reactivation in a single sample; expensive; organisational problems
Heterophile antibodies Useful in distinguishing late primary infection (transient) reactivation when positive; inexpensive and simple Not very sensitive (especially in children)
Anti-EA(D) IgG Useful for EBV reactivation follow-up Not useful in distinguishing late primary infection (transient) from reactivation in a single sample
CLIA for EBV antibodies with differential cut-off values Useful in distinguishing primary infection (transient) from past infection; can be used for screening Requires further study

EBV: Epstein-Barr virus; EBNA: EBV nuclear antigen; CLIA: Chemiluminescence immunoassay.